Ezetimibe is a medication used to lower cholesterol levels in the blood. It works by reducing the absorption of cholesterol from the small intestine. According to the sources provided, there is no direct recommendation for the use of ezetimibe in low-fat diets.

The first source, Drug Patent Watch [1], provides information about the patent status of ezetimibe and its manufacturers. It does not provide any information about the use of ezetimibe in low-fat diets.

The second source, MedlinePlus [2], is a reliable source of information about medications approved by the US Food and Drug Administration (FDA). According to MedlinePlus, ezetimibe is usually taken once a day, with or without food. However, there is no information on whether ezetimibe is recommended for use in low-fat diets.

The third source, a study published in the Journal of the American College of Cardiology [3], evaluated the effects of ezetimibe on cholesterol levels in patients with high cholesterol levels. The study found that ezetimibe reduced cholesterol levels by inhibiting the absorption of cholesterol in the small intestine. However, the study did not provide any recommendations for the use of ezetimibe in low-fat diets.

In conclusion, based on the sources provided, there is no direct recommendation for the use of ezetimibe in low-fat diets. While ezetimibe is used to lower cholesterol levels, it is usually taken once a day with or without food, and there is no information on whether it is recommended for use in low-fat diets.

Sources:

[1] Drug Patent Watch. Ezetimibe. https://www.drugpatentwatch.com/p/tradename/EZETIMIBE

[2] MedlinePlus. Ezetimibe. https://medlineplus.gov/druginfo/meds/a603015.html

[3] Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. J Am Coll Cardiol. 2001 Dec;38(7):1696-703. doi: 10.1016/s0735-1097(01)01604-4. PMID: 11742881.